Wilmington Savings Fund Society’s ARK Genomic Revolution ETF ARKG Stock Holding History

Wilmington Savings Fund Society’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$270K	Buy	6,425 +6,375	+12,750%	+$203K	0.01%	525
2026 Q1	$1.32K	Buy	+50	New	+$1.46K	﹤0.01%	1376
2025 Q4	–	Sell	-50	Closed	-$1.39K	–	1379
2025 Q3	$1.39K	Buy	+50	New	+$1.26K	﹤0.01%	1320
2025 Q2	–	Sell	-20	Closed	-$415	–	2050
2025 Q1	$415	Hold	20	–	–	﹤0.01%	2021
2024 Q4	$471	Hold	20	–	–	﹤0.01%	2038
2024 Q3	$512	Buy	+20	New	+$509	﹤0.01%	2013

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wilmington Savings Fund Society's ARKG Position: Q2 2026 in Review

Wilmington Savings Fund Society increased its ARK Genomic Revolution ETF (ARKG) stake by 12,750% in Q2 2026, buying an estimated $203K and bringing the position to 6,425 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #525.

Wilmington Savings Fund Society first reported a position in ARKG in Q3 2024 and has held it in 6 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Wilmington Savings Fund Society held 6,425 shares of ARK Genomic Revolution ETF worth $270K as of Q2 2026.
Wilmington Savings Fund Society bought 6,375 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $203K.
ARK Genomic Revolution ETF made up 0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #525 holding.
Wilmington Savings Fund Society first reported a position in ARK Genomic Revolution ETF in Q3 2024 and has held it in 6 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.